SC Pembro, Biotin, P5-yr POLARIX data
Update: 2025-09-25
Description
The long awaited subcutaneous formulation of pembrolizumab is not FDA-approved. We discuss its administration and toxicity & PK differences vs. IV use.
Biotin supplementation can interfere with lots of labs cancer patients get routinely - Who knew? (Ahem, not me.) Link: https://doi.org/10.1200/OP-25-00693
POLARIX 5-year Data: https://doi.org/10.1200/JCO-25-00925
Biotin supplementation can interfere with lots of labs cancer patients get routinely - Who knew? (Ahem, not me.) Link: https://doi.org/10.1200/OP-25-00693
POLARIX 5-year Data: https://doi.org/10.1200/JCO-25-00925
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
